Press

Operating below the radar, IveaCare is rapidly building an interdisciplinary team combining deep expertise from leading clinical research, neuroscience, and eng...

MINNEAPOLIS, April 22, 2024 — iVEAcare, a privately held, development stage medical device company, announced the close of a $27.5 million Series A financing.